218 related articles for article (PubMed ID: 36077095)
1. Regulation of Expression of Cannabinoid CB
Lillo J; Raïch I; Silva L; Zafra DA; Lillo A; Ferreiro-Vera C; Sánchez de Medina V; Martínez-Orgado J; Franco R; Navarro G
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077095
[No Abstract] [Full Text] [Related]
2. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of cannabinoid CB
Franco R; Villa M; Morales P; Reyes-Resina I; Gutiérrez-Rodríguez A; Jiménez J; Jagerovic N; Martínez-Orgado J; Navarro G
Neuropharmacology; 2019 Jul; 152():58-66. PubMed ID: 30738036
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors.
Pazos MR; Mohammed N; Lafuente H; Santos M; Martínez-Pinilla E; Moreno E; Valdizan E; Romero J; Pazos A; Franco R; Hillard CJ; Alvarez FJ; Martínez-Orgado J
Neuropharmacology; 2013 Aug; 71():282-91. PubMed ID: 23587650
[TBL] [Abstract][Full Text] [Related]
5. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.
Espejo-Porras F; Fernández-Ruiz J; Pertwee RG; Mechoulam R; García C
Neuropharmacology; 2013 Dec; 75():155-63. PubMed ID: 23924692
[TBL] [Abstract][Full Text] [Related]
6. Expression of GPR55 and either cannabinoid CB
Martínez-Pinilla E; Rico AJ; Rivas-Santisteban R; Lillo J; Roda E; Navarro G; Lanciego JL; Franco R
Brain Struct Funct; 2020 Sep; 225(7):2153-2164. PubMed ID: 32691218
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents.
Bi GH; Galaj E; He Y; Xi ZX
Addict Biol; 2020 Jul; 25(4):e12783. PubMed ID: 31215752
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol skews biased agonism at cannabinoid CB
Navarro G; Reyes-Resina I; Rivas-Santisteban R; Sánchez de Medina V; Morales P; Casano S; Ferreiro-Vera C; Lillo A; Aguinaga D; Jagerovic N; Nadal X; Franco R
Biochem Pharmacol; 2018 Nov; 157():148-158. PubMed ID: 30194918
[TBL] [Abstract][Full Text] [Related]
10. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB
Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240
[TBL] [Abstract][Full Text] [Related]
11. Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals.
Galaj E; Xi ZX
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374481
[TBL] [Abstract][Full Text] [Related]
12. Differential contribution of CB1, CB2, 5-HT1A, and PPAR-γ receptors to cannabidiol effects on ischemia-induced emotional and cognitive impairments.
Mori MA; Meyer E; da Silva FF; Milani H; Guimarães FS; Oliveira RMW
Eur J Neurosci; 2021 Mar; 53(6):1738-1751. PubMed ID: 33522084
[TBL] [Abstract][Full Text] [Related]
13. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
Pertwee RG
Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action.
Chaves YC; Genaro K; Crippa JA; da Cunha JM; Zanoveli JM
Metab Brain Dis; 2021 Apr; 36(4):639-652. PubMed ID: 33464458
[TBL] [Abstract][Full Text] [Related]
15. Identification of the Ghrelin and Cannabinoid CB
Lillo J; Lillo A; Zafra DA; Miralpeix C; Rivas-Santisteban R; Casals N; Navarro G; Franco R
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445634
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol regulates behavioural alterations and gene expression changes induced by spontaneous cannabinoid withdrawal.
Navarrete F; Aracil-Fernández A; Manzanares J
Br J Pharmacol; 2018 Jul; 175(13):2676-2688. PubMed ID: 29624642
[TBL] [Abstract][Full Text] [Related]
17. The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling.
Fogaça MV; Campos AC; Coelho LD; Duman RS; Guimarães FS
Neuropharmacology; 2018 Jun; 135():22-33. PubMed ID: 29510186
[TBL] [Abstract][Full Text] [Related]
18. Cannabidiol Anticonvulsant Effects Against Lithium-Pilocarpine-Induced Status Epilepticus in Male Rats Are Mediated by Neuroinflammation Modulation and Cannabinoids 1 (CB1), But Not CB2 and GABA
Masoumi M; Manavi MA; Mohammad Jafari R; Mirzaei A; Hedayatyanfard K; Beigmohammadi MT; Dehpour AR
Cannabis Cannabinoid Res; 2024 Jun; 9(3):797-808. PubMed ID: 37976207
[No Abstract] [Full Text] [Related]
19. Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors.
Sagredo O; Ramos JA; Decio A; Mechoulam R; Fernández-Ruiz J
Eur J Neurosci; 2007 Aug; 26(4):843-51. PubMed ID: 17672854
[TBL] [Abstract][Full Text] [Related]
20. Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist.
Cascio MG; Gauson LA; Stevenson LA; Ross RA; Pertwee RG
Br J Pharmacol; 2010 Jan; 159(1):129-41. PubMed ID: 20002104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
